TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
0.6910
-0.0200 (-2.81%)
At close: Jul 24, 2026, 4:00 PM EDT
0.7000
+0.0090 (1.30%)
After-hours: Jul 24, 2026, 4:10 PM EDT

TELA Bio Revenue

TELA Bio had revenue of $19.06M in the quarter ending March 31, 2026, with 2.91% growth. This brings the company's revenue in the last twelve months to $80.81M, up 13.48% year-over-year. In the year 2025, TELA Bio had annual revenue of $80.28M with 15.84% growth.

Revenue (ttm)
$80.81M
Revenue Growth
+13.48%
P/S Ratio
0.38
Revenue / Employee
$370,706
Employees
218
Market Cap
30.93M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202580.28M10.98M15.84%
Dec 31, 202469.30M10.85M18.56%
Dec 31, 202358.45M17.04M41.13%
Dec 31, 202241.42M11.96M40.58%
Dec 31, 202129.46M11.25M61.77%
Dec 31, 202018.21M2.77M17.91%
Dec 31, 201915.45M7.17M86.68%
Dec 31, 20188.27M4.03M94.91%
Dec 31, 20174.25M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Accuray428.57M
Nortech Systems121.79M
Myomo41.21M
Cytosorbents37.20M
QT Imaging Holdings22.66M
Baird Medical Investment Holdings22.54M
Pulsenmore12.55M
Elutia12.46M
Revenue Rankings